| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From the Institute of Biomedical Sciences, Academia Sinica, Nan-Kang, Taipei, Taiwan, ROC (W-TY, L-SH, and W-HP); the Center for Health Policy Research and Development, National Health Research Institutes, Zhunan, Taiwan, ROC (H-YC and Y-WW); the Department of Economics, National Tong-Hua University, Hualien, Taiwan, ROC (Y-WH); the Department of Statistics, National Cheng-Chi University, Taipei, Taiwan, ROC (C-SJY); the Graduate Institute of Applied Science of Living, Chinese Culture University, Taipei, Taiwan, ROC (S-YT); and the Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, Taipei, Taiwan, ROC (W-HP)
Background:The beneficial effects of potassium-enriched salt on blood pressure have been reported in a few short-term trials. The long-term effects of potassium-enriched salt on cardiovascular mortality have not been carefully studied.
Objective:The objective was to examine the effects of potassium-enriched salt on cardiovascular disease (CVD) mortality and medical expenditures in elderly veterans.
Design:Five kitchens of a veteran retirement home were randomized into 2 groups (experimental or control) and veterans assigned to those kitchens were given either potassium-enriched salt (experimental group) or regular salt (control group) for 
31 mo. Information on death, health insurance claims, and dates that veterans moved in or out of the home was gathered.
Results:Altogether, 1981 veterans, 768 in the experimental [
(±SD) age: 74.8 ± 7.1 y] and 1213 in the control (age: 74.9 ± 6.7 y) groups, were included in the analysis. The experimental group had better CVD survivorship than did the control group. The incidence of CVD-related deaths was 13.1 per 1000 persons (27 deaths in 2057 person-years) and 20.5 per 1000 (66 deaths in 3218 person-years) for the experimental and control groups, respectively. A significant reduction in CVD mortality (age-adjusted hazard ratio: 0.59; 95% CI: 0.37, 0.95) was observed in the experimental group. Persons in the experimental group lived 0.3–0.90 y longer and spent significantly less (US $426/y) in inpatient care for CVD than did the control group, after control for age and previous hospitalization expenditures.
Conclusions:This study showed a long-term beneficial effect on CVD mortality and medical expenditure associated with a switch from regular salt to potassium-enriched salt in a group of elderly veterans. The effect was likely due to a major increase in potassium and a moderate reduction in sodium intakes.
Key Words: Potassium-enriched salt • elderly • cardiovascular mortality • health expenditure • Taiwan
This article has been cited by other articles:
|
|
 |
|
  C. K. Chow Does potassium-enriched salt or sodium reduction reduce cardiovascular mortality and medical expenses? Am. J. Clinical Nutrition, December 1, 2006; 84(6): 1552 - 1553. [Full Text] [PDF]
|
|
|
|
|
|
H.-Y. Chang and W.-H. Pan Reply to CK Chow Am. J. Clinical Nutrition, December 1, 2006; 84(6): 1553 - 1554. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Parikh and S. Coca Long term dietary use of potassium enriched salt reduced cardiovascular death in elderly men Evid. Based Med., December 1, 2006; 11(6): 172 - 172. [Full Text] [PDF]
|
|
|
|
 |
|
 B. N. Ames Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage PNAS, November 21, 2006; 103(47): 17589 - 17594. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Salt enriched with potassium reduces cardiovascular mortality in older men BMJ, July 1, 2006; 333(7557): . [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
